Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 2/20 | 0.45 |
| ▸ | NT5E | P21589 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
| ▸ | CASP6 | P55212 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | NSD2 | O96028 | 1/20 | 0.42 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4812412 | 0.90 | ALDH1A1 (0.52) | CASRNT5EALDH1A1HSD17B10CASP6 | |
| SCHEMBL11331642 | 0.88 | ALDH1A1 (0.50) | CASRNT5EALDH1A1HSD17B10CASP6 | |
| SCHEMBL8636120 | 0.86 | CASR (0.47) | CASRNT5EALDH1A1HSD17B10CASP6 | |
| Acetoacetic Acid SCHEMBL11500881 | 0.85 | CASR (0.47) | CASRNT5EALDH1A1HSD17B10CASP6 | |
| SCHEMBL6935562 | 0.80 | CASP6 (0.53) | NT5EALDH1A1HSD17B10CASP6CYP2C9 | |
| SCHEMBL29918476 | 0.80 | NT5E (0.47) | NT5EALDH1A1HSD17B10CASP6CYP2C9 | |
| SCHEMBL7709568 | 0.80 | NT5E (0.47) | NT5EALDH1A1HSD17B10CASP6CYP2C9 | |
| SCHEMBL8376960 | 0.79 | CA1 (0.43) | ALDH1A1HSD17B10GAAL3MBTL1TSHR | |
| SCHEMBL17262954 | 0.78 | ALDH1A1 (0.60) | NT5EALDH1A1HSD17B10CASP6CYP2C9 | |
| SCHEMBL9297596 | 0.78 | NT5E (0.46) | NT5EALDH1A1HSD17B10CASP6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11137657-A | — | — | None | — | — | JP | disclosed |
| EP-3730134-B1 | MEDICINAL COMPOSITION FOR PREVENTING OR TREATING SECONDARY HYPERPARATHYROIDISM UNDER MAINTENANCE DIALYSIS | EA PHARMA CO LTD (JP) | 2025-05-14 | — | — | EP | disclosed |
| US-RE49569-E1 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| CN-116332809-A | Process for producing alkylamine derivative and intermediate for production thereof | 味之素株式会社 | 2023-06-27 | — | — | CN | disclosed |
| CN-115536556-A | Process for producing alkylamine derivative and intermediate for producing the same | 味之素株式会社 | 2022-12-30 | — | — | CN | disclosed |
| US-20220142958-A1 | MEDICINAL COMPOSITION HAVING EXCELLENT STABILITY | EA PHARMA CO., LTD. (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220142958-A1 | MEDICINAL COMPOSITION HAVING EXCELLENT STABILITY | EA PHARMA CO., LTD. (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11311508-B2 | Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis | EA PHARMA CO., LTD. (JP) | 2022-04-26 | — | — | US | disclosed |
| EP-3950058-A1 | PHARMACEUTICAL COMPOSITION HAVING FAVORABLE STABILITY | EA Pharma Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-113260416-A | Pharmaceutical composition with good stability | EA制药株式会社 | 2021-08-13 | — | — | CN | disclosed |
| US-4576973-A | ADSORBENT BEAD | CASSELLA AKTIENGESELLSCHAFT (DE) | 1986-03-18 | — | — | US | disclosed |
| US-4552905-A | VINYL-SUBSTITUTED PYRIDINE, QUINOLINE, ISO-QUINOLINE, OR PYRAZINE;N-VINYLAMIDE, CROSSLINKER | CASSELLA AKTIENGESELLSCHAFT (DE) | 1985-11-12 | — | — | US | disclosed |
| EP-0134921-A1 | Copolymer, process for its preparation and its use as a sorbent | CASSELLA Aktiengesellschaft (DE) | 1985-03-27 | — | — | EP | disclosed |
| EP-0073406-B1 | WATER-SOLUBLE MONOAZO PYRAZOLONE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-03-20 | — | — | EP | disclosed |
| EP-0131179-A1 | Copolymer, process for its preparation and its use as a sorbent | CASSELLA Aktiengesellschaft (DE) | 1985-01-16 | — | — | EP | disclosed |
| EP-0056975-B1 | WATER SOLUBLE MONOAZOCOMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-01-16 | — | — | EP | disclosed |
| EP-0103156-A2 | Copper complex of water soluble disazo compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-03-21 | — | — | EP | disclosed |
| EP-0073406-A1 | Water-soluble monoazo pyrazolone compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-03-09 | — | — | EP | disclosed |
| EP-0056975-A2 | Water soluble monoazocompounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-08-04 | — | — | EP | disclosed |
| US-4035350-A | Process for the preparation of water-soluble azo dyestuffs by reacting an aromatic amine and a coupling component with alkali metal nitrite or alkyl nitrite in the absence of acid | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11311508-B2 | Medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis | PTH1R, PTMS, REN | CASR 13/4885NT5E 1869/4885ALDH1A1 3730/4885 |
| US-20220142958-A1 | MEDICINAL COMPOSITION HAVING EXCELLENT STABILITY | UGT2B7, TPMT, CEL | CASR 2569/4885NT5E 3216/4885ALDH1A1 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.